Wearables and other technology to facilitate decentralized trials were supposed to ease patient burden. Elisa Cascade explains why the results depend entirely on design.
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Navigating The eCOA Vendor Landscape In 2025
This guide offers a clear-eyed perspective on the current eCOA landscape, providing sponsors with actionable guidance to make confident, informed vendor choices.
-
eConsent For Complex Clinical Trials
Master protocol design trials require an endless stream of consent forms, adding time, cost, and risk. Learn how a feature-rich eConsent platform can simplify those processes and improve engagement.
-
Why Legacy RTSM Systems Create Risk in Biosimilar Trials
Learn how real-time visibility, adaptive supply planning, and proactive risk management can reduce waste and improve study execution.
-
Leveraging The Window Of Opportunity In Clinical Trial Recruitment
Access to real-world data now makes it possible to identify potential trial participants, wherever they are.
-
Clinical Trial Technology Report Showcases 2023 Trends: Site Enablement, eISFs, And Integrations
Dive into six insights to stay on top of the rapidly shifting research industry and to ensure your research organization doesn’t get left behind.
-
The Intelligent Teammate: Agentic AI As A Catalyst For Clinical Innovation
Agentic AI cuts variability, speeds clinical workflows, and strengthens compliance. It boosts efficiency and supports teams as research demands grow. Explore the full article for insights.
-
EDC Powers End-To-End Data Management In Pharma-Sponsored Trials
As clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.
-
The Hidden Cost Of Preferred Vendors
Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.
-
Why The TrialKit Platform License Agreement Changes The Economics Of Clinical Trials
A platform‑based pricing model removes change‑order friction, enabling predictable budgets and faster study adjustments. It supports operational agility and portfolio‑level efficiency as trials evolve.
-
Inova Health System Uses Advarra eReg Workflows And Integrations To Improve Regulatory Efficiency
Maintaining efficient, effective regulatory management processes can be a significant challenge. At Inova Health System, the research team improved regulatory efficiency by 20% without the need for extra regulatory staff by adopting Advarra’s eRegulatory Management System.
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
RECENT NEWSLETTERS
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution